BrightSpring Health Services, Inc.
BTSGdata completeness 100%4 fiscal years on fileData notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'
BrightSpring Health Services, Inc. earns about 6% on invested capital, but has diluted owners by 87% over 4 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue | $7.72B1 | $7.69B2 | $10.1B2 | $12.9B2 |
| Net income | −$53.9M3 | −$154.6M4 | −$18.1M4 | $190.7M4 |
| Operating cash flow | −$4.65M5 | $210.8M6 | $23.8M6 | $490.2M6 |
| Capital expenditure | $70.1M7 | $73.5M8 | $80.9M8 | $95.5M8 |
| Free cash flow (derived) | −$74.8M5 | $137.3M6 | −$57.1M6 | $394.7M6 |
| Total debt | — | $6.73B9 | $5.22B10 | $5.02B10 |
| Cash & equivalents | — | $13.1M11 | $61M12 | $88.4M12 |
| Diluted shares | 117.8M | 117.9M | 193.0M | 219.8M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $85.32 of net worth that earned you $8.68 and generated $17.96 of cash last year, against $228.19 of debt.
It earned an average 6% on invested capital over 4 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 87% over 4 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 25% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth5.0%
- fcfBase$137.3M
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth5.0%
- fcfBase$137.3M
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-12-31 · accession 0000950170-25-034196 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-079454 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-034196 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-079454 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-034196 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-079454 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-034196 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-079454 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0000950170-25-034196 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0001193125-26-079454 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0000950170-25-034196 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001193125-26-079454 (CashAndCashEquivalentsAtCarryingValue)